Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020

SELL
$127.12 - $172.34 $378,054 - $512,539
-2,974 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$93.0 - $171.7 $276,582 - $510,635
2,974 New
2,974 $477,000
Q1 2020

May 13, 2020

SELL
$82.38 - $131.64 $207,103 - $330,942
-2,514 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$76.53 - $135.58 $48,366 - $85,686
-632 Reduced 20.09%
2,514 $324,000
Q3 2019

Nov 12, 2019

BUY
$72.81 - $156.91 $65,383 - $140,905
898 Added 39.95%
3,146 $237,000
Q2 2019

Aug 13, 2019

SELL
$112.21 - $151.95 $2.26 Million - $3.06 Million
-20,139 Reduced 89.96%
2,248 $342,000
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $2.39 Million - $3.4 Million
22,387 New
22,387 $2.67 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.